7 Elements of a Successful Biotech Funding Plan
CEOs must accept the reality that the success of their company is largely dependent on segment dynamics, in addition to the technology or their management skills
7 Elements of a Successful Biotech Funding Plan
Published in Life Science Leader, November 2019
Authors: Dr. Ellen Baron and Dr. Oded Ben-Joseph
Abstract:
Life sciences companies seeking to raise capital or form early partnerships with strategic players often make avoidable mistakes based on misconceptions stem- ming from management’s internal perspective or from overlooking segment dynamics and the importance of return on capital to investors. But there are some tips that can increase your probability of a successful transaction.
News
Outcome Capital and YAFO Capital Announce Strategic Partnership to Expand Global Strategic and Financial Services to Biopharma and Healthcare Clients
The collaboration will allow the partners to globally expand financial advisory services and cross-border transactions for life sciences and biopharmaceutical client companies Boston & Shanghai – September 14, 2023. Outcome Capital, a specialized life science advisory and investment banking firm, and YAFO Capital, a Shanghai-based boutique investment banking and advisory firm, announced that the companies […]
Read MoreResources
Outcome Capital Life Sciences Pulse, August 2023
Outcome Capital Life Science Market Pulse August 2023 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2023. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Business Continuity Plan | Privacy Policy
